Centre of Excellence in Nanotechnology & Pharmaceutics Division
Centre of Excellence in Nanotechnology & Pharmaceutics Division
Centre of Excellence in Nanotechnology & Pharmaceutics Division

(Rungta College of Pharmaceutical Sciences & Research, Bhilai)
Objectives of the Centre
- To develop advanced nanocarrier-based drug delivery systems for chronic and life-threatening diseases
- To promote translational research bridging laboratory discoveries to clinical applications
- To foster interdisciplinary collaboration with academia, industry, and healthcare institutions
- To nurture skilled research professionals through training and doctoral programs
- To support indigenous innovation and technology commercialization
Members
Centre Members
Dr. Madhulika Pradhan
In-Charge
Professor, School of Pharmacy, Rungta International Skills University
Scopus ID: 55566006700
Dr. Sanjay Gupta
Member
Professor, School of Pharmacy, Rungta International Skills University
Scopus ID: 55584796634
Dr. Parag Jain
Member
Professor, School of Pharmacy, Rungta International Skills University
Scopus ID: 54981246800
Dr. Krishna Yadav
Member
Associate Professor, School of Pharmacy, Rungta International Skills University
Scopus ID: 57202978016
- Hands-on training in nanotechnology and advanced pharmaceutics
- Faculty Development Programs (FDPs)
- Workshops on drug delivery systems and formulation development
- Collaborative research and industry-oriented projects
- Conferences and skill development programs
Conference
International Conference on Nanotechnology and Advanced Drug Delivery Systems for Global Healthcare
The International Conference on Nanotechnology and Advanced Drug Delivery Systems for Global Healthcare successfully provided a multidisciplinary platform for researchers, academicians, industry experts, and students. The conference significantly enhanced awareness regarding emerging nanopharmaceutical technologies, translational research, and precision medicine while strengthening the research ecosystem of the Centre of Excellence i Nanotechnology & Pharmaceutics Division. The event contributed substantially toward fostering innovation, collaboration, and technology-driven healthcare solutions.
Conference Convenor
Dr. Madhulika Pradhan
Centre of Excellence in Nanotechnology & Pharmaceutics Division
Abstract Submission Deadline: 15 December 2024
Full Paper Submission Deadline: 15 January 2025
Notification of Acceptance: 31 January 2025
Camera Ready Submission: 15 February 2025
Early Bird Registration Deadline: 31 January 2025
Final Registration Deadline: 28 February 2025
Conference Dates: 16–17 March 2025
- Nanotechnology-Based Drug Delivery Systems and Nanomedicine
- Advanced Pharmaceutical Formulations, Biomaterials and Therapeutic Innovations
- Targeted, Controlled and Stimuli-Responsive Drug Delivery Technologies
- Translational Nanomedicine, Diagnostics and Personalized Healthcare
- Regulatory, Safety, Commercialization and Global Health Applications of Nanotechnology
- Abstract should be 250–300 words including title, authors, affiliation, and keywords
- Format: MS Word or PDF
- Full-length papers are encouraged for proceedings publication
- Submission via email
Email: dr.madhulika.pradhan@rungta.org
